TreeWAS – Variant ID: rs11726248

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.965	0.035
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.965	0.035
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.966	0.034
T43.2 Other and unspecified antidepressants	0.000	0.966	0.034
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.967	0.033
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.967	0.033
T39.0 Salicylates	0.000	0.967	0.033
D13.1 Stomach	0.030	0.970	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.971	0.029
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.971	0.029
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.972	0.028
T39.1 4-Aminophenol derivatives	0.000	0.972	0.028
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.972	0.028
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.972	0.028
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.973	0.027
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.974	0.026
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.975	0.025
T43.9 Psychotropic drug, unspecified	0.000	0.975	0.025
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.975	0.025
T43.6 Psychostimulants with abuse potential	0.000	0.975	0.025
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.975	0.025
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.975	0.025
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.975	0.025
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.975	0.025
T39.4 Antirheumatics, not elsewhere classified	0.000	0.975	0.025
T39.2 Pyrazolone derivatives	0.000	0.975	0.025
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.975	0.025
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.975	0.025
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.975	0.025
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.975	0.025
T50.8 Diagnostic agents	0.000	0.976	0.024
T50.7 Analeptics and opioid receptor antagonists	0.000	0.976	0.024
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.976	0.024
T50.5 Appetite depressants	0.000	0.976	0.024
T50.4 Drugs affecting uric acid metabolism	0.000	0.976	0.024
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.976	0.024
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.976	0.024
T50.1 Loop [high-ceiling] diuretics	0.000	0.976	0.024
T50.0 Mineralocorticoids and their antagonists	0.000	0.976	0.024
T36 Poisoning by systemic antibiotics	0.000	0.976	0.024
B02.9 Zoster without complication	0.023	0.977	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.977	0.023
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.977	0.022
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.979	0.021
T42.4 Benzodiazepines	0.000	0.979	0.021
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.979	0.021
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.979	0.020
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.979	0.020
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.980	0.020
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.980	0.020
T42.3 Barbiturates	0.000	0.980	0.020
T42.2 Succinimides and oxazolidinediones	0.000	0.980	0.020
T42.0 Hydantoin derivatives	0.000	0.980	0.020
T40.4 Other synthetic narcotics	0.000	0.980	0.020
T42.1 Iminostilbenes	0.000	0.981	0.019
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.981	0.019
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.981	0.019
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.981	0.019
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.981	0.019
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.981	0.019
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.981	0.019
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.981	0.019
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.981	0.019
T44.0 Anticholinesterase agents	0.000	0.981	0.019
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.981	0.019
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.981	0.019
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.981	0.019
T47.7 Emetics	0.000	0.981	0.019
T47.6 Antidiarrhoeal drugs	0.000	0.981	0.019
T47.5 Digestants	0.000	0.981	0.019
T47.4 Other laxatives	0.000	0.981	0.019
T47.3 Saline and osmotic laxatives	0.000	0.981	0.019
T47.2 Stimulant laxatives	0.000	0.981	0.019
T47.0 Histamine H(2)-receptor antagonists	0.000	0.981	0.019
S00.1 Contusion of eyelid and periocular area	0.019	0.981	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.982	0.018
T40.8 Lysergide [LSD]	0.000	0.982	0.018
T40.7 Cannabis (derivatives)	0.000	0.982	0.018
T40.5 Cocaine	0.000	0.982	0.018
T40.3 Methadone	0.000	0.982	0.018
T40.1 Heroin	0.000	0.982	0.018
T40.0 Opium	0.000	0.982	0.018
T40.6 Other and unspecified narcotics	0.000	0.982	0.018
S00.0 Superficial injury of scalp	0.018	0.982	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.982	0.018
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.982	0.018
T37.5 Antiviral drugs	0.000	0.982	0.018
T37.4 Anthelminthics	0.000	0.982	0.018
T37.3 Other antiprotozoal drugs	0.000	0.982	0.018
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.982	0.018
T37.1 Antimycobacterial drugs	0.000	0.982	0.018
T37.0 Sulphonamides	0.000	0.982	0.018
T41.5 Therapeutic gases	0.000	0.982	0.018
T41.4 Anaesthetic, unspecified	0.000	0.982	0.018
T41.3 Local anaesthetics	0.000	0.982	0.018
T41.2 Other and unspecified general anaesthetics	0.000	0.982	0.018
T41.1 Intravenous anaesthetics	0.000	0.982	0.018
T41.0 Inhaled anaesthetics	0.000	0.982	0.018
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.982	0.018
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.982	0.018
T48.5 Anti-common-cold drugs	0.000	0.982	0.018
T48.4 Expectorants	0.000	0.982	0.018
T48.3 Antitussives	0.000	0.982	0.018
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.982	0.018
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.982	0.018
T48.0 Oxytocic drugs	0.000	0.982	0.018
T49.9 Topical agent, unspecified	0.000	0.982	0.018
T49.8 Other topical agents	0.000	0.982	0.018
T49.7 Dental drugs, topically applied	0.000	0.982	0.018
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.982	0.018
T49.5 Ophthalmological drugs and preparations	0.000	0.982	0.018
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.982	0.018
T49.3 Emollients, demulcents and protectants	0.000	0.982	0.018
T49.2 Local astringents and local detergents	0.000	0.982	0.018
T49.1 Antipruritics	0.000	0.982	0.018
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.982	0.018
S00 Superficial injury of head	0.018	0.982	0.000
K31.9 Disease of stomach and duodenum, unspecified	0.018	0.982	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.983	0.017
T36.8 Other systemic antibiotics	0.000	0.983	0.017
T36.7 Antifungal antibiotics, systemically used	0.000	0.983	0.017
T36.6 Rifamycins	0.000	0.983	0.017
T36.5 Aminoglycosides	0.000	0.983	0.017
T36.4 Tetracyclines	0.000	0.983	0.017
T36.3 Macrolides	0.000	0.983	0.017
T36.2 Chloramphenicol group	0.000	0.983	0.017
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.983	0.017
T40.2 Other opioids	0.000	0.983	0.017
T45.0 Antiallergic and antiemetic drugs	0.000	0.983	0.017
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.984	0.016
T45.8 Other primarily systemic and haematological agents	0.000	0.984	0.016
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.984	0.016
T45.6 Fibrinolysis-affecting drugs	0.000	0.984	0.016
T45.4 Iron and its compounds	0.000	0.984	0.016
T45.3 Enzymes, not elsewhere classified	0.000	0.984	0.016
T36.0 Penicillins	0.000	0.984	0.016
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.984	0.016
S00.9 Superficial injury of head, part unspecified	0.016	0.984	0.000
T45.2 Vitamins, not elsewhere classified	0.000	0.985	0.015
T45.5 Anticoagulants	0.000	0.985	0.015
T38.9 Other and unspecified hormone antagonists	0.000	0.985	0.015
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.985	0.015
T38.7 Androgens and anabolic congeners	0.000	0.985	0.015
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.985	0.015
T38.5 Other oestrogens and progestogens	0.000	0.985	0.015
T38.4 Oral contraceptives	0.000	0.985	0.015
T38.2 Antithyroid drugs	0.000	0.985	0.015
T38.0 Glucocorticoids and synthetic analogues	0.000	0.985	0.015
S00.3 Superficial injury of nose	0.015	0.985	0.000
S00.4 Superficial injury of ear	0.015	0.985	0.000
S00.2 Other superficial injuries of eyelid and periocular area	0.014	0.986	0.000
T38.1 Thyroid hormones and substitutes	0.000	0.986	0.014
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.986	0.014
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.986	0.014
T46.7 Peripheral vasodilators	0.000	0.986	0.014
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.986	0.014
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.986	0.014
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.986	0.014
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.986	0.014
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.986	0.014
S00.5 Superficial injury of lip and oral cavity	0.013	0.987	0.000
T46.1 Calcium-channel blockers	0.000	0.988	0.012
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.988	0.012
B02 Zoster [herpes zoster]	0.012	0.988	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.988	0.011
S00.7 Multiple superficial injuries of head	0.011	0.989	0.000
S00.8 Superficial injury of other parts of head	0.010	0.990	0.000
B02.8 Zoster with other complications	0.009	0.991	0.000
B02.7 Disseminated zoster	0.009	0.991	0.000
B02.1 Zoster meningitis	0.009	0.991	0.000
B02.0 Zoster encephalitis	0.009	0.991	0.000
K31.8 Other specified diseases of stomach and duodenum	0.009	0.991	0.000
B02.3 Zoster ocular disease	0.009	0.991	0.000
B02.2 Zoster with other nervous system involvement	0.008	0.992	0.000
K31 Other diseases of stomach and duodenum	0.008	0.992	0.000
K31.5 Obstruction of duodenum	0.007	0.993	0.000
D13 Benign neoplasm of other and ill-defined parts of digestive system	0.007	0.993	0.000
K13.0 Diseases of lips	0.006	0.994	0.000
K82.8 Other specified diseases of gallbladder	0.006	0.994	0.000
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.006	0.994	0.000
K31.6 Fistula of stomach and duodenum	0.006	0.994	0.000
K31.3 Pylorospasm, not elsewhere classified	0.006	0.994	0.000
K31.2 Hourglass stricture and stenosis of stomach	0.006	0.994	0.000
K31.0 Acute dilatation of stomach	0.006	0.994	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.000	0.994	0.006
D13.3 Other and unspecified parts of small intestine	0.006	0.994	0.000
D13.4 Liver	0.005	0.995	0.000
K13 Other diseases of lip and oral mucosa	0.005	0.995	0.000
D13.9 Ill-defined sites within the digestive system	0.005	0.995	0.000
D13.7 Endocrine pancreas	0.005	0.995	0.000
D13.6 Pancreas	0.005	0.995	0.000
I69.1 Sequelae of intracerebral haemorrhage	0.000	0.995	0.005
B08 Other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified	0.005	0.995	0.000
B07 Viral warts	0.005	0.995	0.000
K13.7 Other and unspecified lesions of oral mucosa	0.005	0.995	0.000
I69 Sequelae of cerebrovascular disease	0.000	0.995	0.005
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.000	0.995	0.005
H40.9 Glaucoma, unspecified	0.005	0.995	0.000
B06 Rubella [German measles]	0.004	0.995	0.000
B05 Measles	0.004	0.995	0.000
B09 Unspecified viral infection characterised by skin and mucous membrane lesions	0.004	0.995	0.000
B04 Monkeypox	0.004	0.995	0.000
B03 Smallpox	0.004	0.995	0.000
K13.6 Irritative hyperplasia of oral mucosa	0.004	0.996	0.000
K31.1 Adult hypertrophic pyloric stenosis	0.004	0.996	0.000
H44.2 Degenerative myopia	0.000	0.996	0.004
B01 Varicella [chickenpox]	0.004	0.996	0.000
K13.4 Granuloma and granuloma-like lesions of oral mucosa	0.004	0.996	0.000
D13.5 Extrahepatic bile ducts	0.004	0.996	0.000
B08.1 Molluscum contagiosum	0.004	0.996	0.000
K13.2 Leukoplakia and other disturbances of oral epithelium, including tongue	0.004	0.996	0.000
K13.5 Oral submucous fibrosis	0.004	0.996	0.000
K13.3 Hairy leukoplakia	0.004	0.996	0.000
K13.1 Cheek and lip biting	0.004	0.996	0.000
B08.8 Other specified viral infections characterised by skin and mucous membrane lesions	0.004	0.996	0.000
B08.5 Enteroviral vesicular pharyngitis	0.004	0.996	0.000
B08.4 Enteroviral vesicular stomatitis with exanthem	0.004	0.996	0.000
B08.3 Erythema infectiosum [fifth disease]	0.004	0.996	0.000
B08.2 Exanthema subitum [sixth disease]	0.004	0.996	0.000
B08.0 Other orthopoxvirus infections	0.004	0.996	0.000
C16.9 Stomach, unspecified	0.004	0.996	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.000	0.996	0.004
F60.9 Personality disorder, unspecified	0.000	0.996	0.004
D13.0 Oesophagus	0.003	0.996	0.000
B05.9 Measles without complication	0.003	0.996	0.000
B05.8 Measles with other complications	0.003	0.996	0.000
B05.4 Measles with intestinal complications	0.003	0.996	0.000
B05.3 Measles complicated by otitis media	0.003	0.996	0.000
B05.2 Measles complicated by pneumonia	0.003	0.996	0.000
B05.1 Measles complicated by meningitis	0.003	0.996	0.000
B05.0 Measles complicated by encephalitis	0.003	0.996	0.000
B06.9 Rubella without complication	0.003	0.996	0.000
B06.8 Rubella with other complications	0.003	0.996	0.000
B06.0 Rubella with neurological complications	0.003	0.996	0.000
B00 Herpesviral [herpes simplex] infections	0.003	0.996	0.000
K31.4 Gastric diverticulum	0.003	0.996	0.001
B01.8 Varicella with other complications	0.003	0.997	0.000
B01.2 Varicella pneumonia	0.003	0.997	0.000
B01.1 Varicella encephalitis	0.003	0.997	0.000
B01.0 Varicella meningitis	0.003	0.997	0.000
C09.9 Tonsil, unspecified	0.003	0.997	0.000
C02.9 Tongue, unspecified	0.003	0.997	0.000
D13.2 Duodenum	0.003	0.997	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.000	0.997	0.003
B01.9 Varicella without complications	0.003	0.997	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.003	0.997	0.000
A04.5 Campylobacter enteritis	0.003	0.997	0.000
O63.1 Prolonged second stage (of labour)	0.003	0.997	0.000
Z36.9 Antenatal screening, unspecified	0.000	0.997	0.003
N13.8 Other obstructive and reflux uropathy	0.003	0.997	0.000
K13.29 Other disturbances of oral epithelium, including tongue	0.003	0.997	0.000
C09 Malignant neoplasm of tonsil	0.003	0.997	0.000
I69.3 Sequelae of cerebral infarction	0.000	0.997	0.003
F60.3 Emotionally unstable personality disorder	0.000	0.997	0.003
C02.4 Lingual tonsil	0.003	0.997	0.000
H43.1 Vitreous haemorrhage	0.000	0.997	0.003
C16 Malignant neoplasm of stomach	0.003	0.997	0.000
F60 Specific personality disorders	0.000	0.997	0.003
M13.96 Arthritis, unspecified (Lower leg)	0.003	0.997	0.000
B00.8 Other forms of herpesviral infection	0.003	0.997	0.000
B00.7 Disseminated herpesviral disease	0.003	0.997	0.000
B00.4 Herpesviral encephalitis	0.003	0.997	0.000
B00.3 Herpesviral meningitis	0.003	0.997	0.000
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis	0.003	0.997	0.000
B00.0 Eczema herpeticum	0.003	0.997	0.000
C02.1 Border of tongue	0.003	0.997	0.000
G47.9 Sleep disorder, unspecified	0.000	0.997	0.003
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.003	0.997	0.000
C16.5 Lesser curvature of stomach, unspecified	0.003	0.997	0.000
B00.5 Herpesviral ocular disease	0.002	0.997	0.000
C02.8 Overlapping lesion of tongue	0.002	0.997	0.000
C02.3 Anterior two-thirds of tongue, part unspecified	0.002	0.997	0.000
C02.2 Ventral surface of tongue	0.002	0.997	0.000
C02.0 Dorsal surface of tongue	0.002	0.997	0.000
H44 Disorders of globe	0.000	0.997	0.003
A63.0 Anogenital (venereal) warts	0.003	0.997	0.000
C91.1 Chronic lymphocytic leukaemia	0.000	0.997	0.003
H72.9 Perforation of tympanic membrane, unspecified	0.000	0.997	0.003
R41.8 Other and unspecified symptoms and signs involving cognitive functions and awareness	0.000	0.997	0.003
C16.0 Cardia	0.003	0.997	0.000
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.002	0.998	0.000
B00.9 Herpesviral infection, unspecified	0.002	0.998	0.000
C09.8 Overlapping lesion of tonsil	0.002	0.998	0.000
C09.1 Tonsillar pillar (anterior) (posterior)	0.002	0.998	0.000
C09.0 Tonsillar fossa	0.002	0.998	0.000
W25.9 Unspecified place	0.000	0.998	0.002
B00.1 Herpesviral vesicular dermatitis	0.002	0.998	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.002	0.998	0.000
K82 Other diseases of gallbladder	0.002	0.998	0.000
C16.6 Greater curvature of stomach, unspecified	0.002	0.998	0.000
C16.8 Overlapping lesion of stomach	0.002	0.998	0.000
C16.4 Pylorus	0.002	0.998	0.000
C16.2 Body of stomach	0.002	0.998	0.000
C16.1 Fundus of stomach	0.002	0.998	0.000
C16.3 Pyloric antrum	0.002	0.998	0.000
F60.8 Other specific personality disorders	0.000	0.998	0.002
F60.7 Dependent personality disorder	0.000	0.998	0.002
F60.6 Anxious [avoidant] personality disorder	0.000	0.998	0.002
F60.5 Anankastic personality disorder	0.000	0.998	0.002
F60.4 Histrionic personality disorder	0.000	0.998	0.002
F60.2 Dissocial personality disorder	0.000	0.998	0.002
F60.1 Schizoid personality disorder	0.000	0.998	0.002
F60.0 Paranoid personality disorder	0.000	0.998	0.002
C06 Malignant neoplasm of other and unspecified parts of mouth	0.002	0.998	0.000
C11 Malignant neoplasm of nasopharynx	0.002	0.998	0.000
M13.93 Arthritis, unspecified (Forearm)	0.002	0.998	0.000
M88.99 Paget's disease of bone, unspecified (Site unspecified)	0.002	0.998	0.000
M88.9 Paget's disease of bone, unspecified	0.002	0.998	0.000
K82.3 Fistula of gallbladder	0.002	0.998	0.000
C10 Malignant neoplasm of oropharynx	0.002	0.998	0.000
C15.9 Oesophagus, unspecified	0.002	0.998	0.000
C07 Malignant neoplasm of parotid gland	0.002	0.998	0.000
C01 Malignant neoplasm of base of tongue	0.002	0.998	0.000
C13 Malignant neoplasm of hypopharynx	0.002	0.998	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.002	0.998	0.000
C05 Malignant neoplasm of palate	0.002	0.998	0.000
C03 Malignant neoplasm of gum	0.002	0.998	0.000
C00 Malignant neoplasm of lip	0.002	0.998	0.000
R41.3 Other amnesia	0.000	0.998	0.002
A63 Other predominantly sexually transmitted diseases, not elsewhere classified	0.002	0.998	0.000
C04 Malignant neoplasm of floor of mouth	0.002	0.998	0.000
C12 Malignant neoplasm of pyriform sinus	0.002	0.998	0.000
S66.2 Injury of extensor muscle and tendon of thumb at wrist and hand level	0.000	0.998	0.002
J18.9 Pneumonia, unspecified	0.000	0.998	0.002
H43 Disorders of vitreous body	0.000	0.998	0.002
H44.9 Disorder of globe, unspecified	0.000	0.998	0.002
H44.8 Other disorders of globe	0.000	0.998	0.002
H44.7 Retained (old) intraocular foreign body, nonmagnetic	0.000	0.998	0.002
H44.6 Retained (old) intraocular foreign body, magnetic	0.000	0.998	0.002
H44.5 Degenerated conditions of globe	0.000	0.998	0.002
H44.4 Hypotony of eye	0.000	0.998	0.002
H44.3 Other degenerative disorders of globe	0.000	0.998	0.002
C14.0 Pharynx, unspecified	0.002	0.998	0.000
H40 Glaucoma	0.002	0.998	0.000
I95.2 Hypotension due to drugs	0.000	0.998	0.002
K12.1 Other forms of stomatitis	0.002	0.998	0.000
K82.1 Hydrops of gallbladder	0.002	0.998	0.000
M13.97 Arthritis, unspecified (Ankle and foot)	0.002	0.998	0.000
C06.2 Retromolar area	0.002	0.998	0.000
D75.1 Secondary polycythaemia	0.000	0.998	0.002
R00.8 Other and unspecified abnormalities of heart beat	0.002	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.998	0.002
H44.1 Other endophthalmitis	0.000	0.998	0.002
J02.9 Acute pharyngitis, unspecified	0.000	0.998	0.002
A04 Other bacterial intestinal infections	0.002	0.998	0.000
C11.9 Nasopharynx, unspecified	0.002	0.998	0.000
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.002	0.998	0.000
C14.2 Waldeyer's ring	0.002	0.998	0.000
K82.0 Obstruction of gallbladder	0.002	0.998	0.000
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s	0.002	0.998	0.000
A09.9 Gastroenteritis and colitis of unspecified origin	0.002	0.998	0.000
C06.9 Mouth, unspecified	0.002	0.998	0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.002	0.998	0.000
C06.1 Vestibule of mouth	0.002	0.998	0.000
C06.0 Cheek mucosa	0.002	0.998	0.000
C15.4 Middle third of oesophagus	0.002	0.998	0.000
H43.3 Other vitreous opacities	0.000	0.998	0.002
R40.0 Somnolence	0.000	0.998	0.002
A50-A64 Infections with a predominantly sexual mode of transmission	0.002	0.998	0.000
C11.8 Overlapping lesion of nasopharynx	0.002	0.998	0.000
C11.3 Anterior wall of nasopharynx	0.002	0.998	0.000
C11.2 Lateral wall of nasopharynx	0.002	0.998	0.000
C11.1 Posterior wall of nasopharynx	0.002	0.998	0.000
C11.0 Superior wall of nasopharynx	0.002	0.998	0.000
C15 Malignant neoplasm of oesophagus	0.002	0.998	0.000
C10.9 Oropharynx, unspecified	0.002	0.998	0.000
C15.0 Cervical part of oesophagus	0.002	0.998	0.000
M88.98 Paget's disease of bone, unspecified (Other)	0.002	0.998	0.000
M88.97 Paget's disease of bone, unspecified (Ankle and foot)	0.002	0.998	0.000
M88.96 Paget's disease of bone, unspecified (Lower leg)	0.002	0.998	0.000
M88.95 Paget's disease of bone, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M88.94 Paget's disease of bone, unspecified (Hand)	0.002	0.998	0.000
M88.93 Paget's disease of bone, unspecified (Forearm)	0.002	0.998	0.000
M88.92 Paget's disease of bone, unspecified (Upper arm)	0.002	0.998	0.000
M88.91 Paget's disease of bone, unspecified (Shoulder region)	0.002	0.998	0.000
C10.8 Overlapping lesion of oropharynx	0.002	0.998	0.000
C10.4 Branchial cleft	0.002	0.998	0.000
C10.3 Posterior wall of oropharynx	0.002	0.998	0.000
C10.2 Lateral wall of oropharynx	0.002	0.998	0.000
C10.1 Anterior surface of epiglottis	0.002	0.998	0.000
C10.0 Vallecula	0.002	0.998	0.000
H40.4 Glaucoma secondary to eye inflammation	0.002	0.998	0.000
M13.9 Arthritis, unspecified	0.002	0.998	0.000
A09 Diarrhoea and gastro-enteritis of presumed infectious origin	0.002	0.998	0.000
S00-S09 Injuries to the head	0.002	0.998	0.000
A04.4 Other intestinal Escherichia coli infections	0.002	0.998	0.000
C00.9 Lip, unspecified	0.002	0.998	0.000
C00.8 Overlapping lesion of lip	0.002	0.998	0.000
C00.6 Commissure of lip	0.002	0.998	0.000
C00.5 Lip, unspecified, inner aspect	0.002	0.998	0.000
C00.4 Lower lip, inner aspect	0.002	0.998	0.000
C00.3 Upper lip, inner aspect	0.002	0.998	0.000
C00.2 External lip, unspecified	0.002	0.998	0.000
C00.1 External lower lip	0.002	0.998	0.000
C00.0 External upper lip	0.002	0.998	0.000
C03.9 Gum, unspecified	0.002	0.998	0.000
C03.1 Lower gum	0.002	0.998	0.000
C03.0 Upper gum	0.002	0.998	0.000
C05.9 Palate, unspecified	0.002	0.998	0.000
C05.8 Overlapping lesion of palate	0.002	0.998	0.000
C05.2 Uvula	0.002	0.998	0.000
C05.1 Soft palate	0.002	0.998	0.000
C05.0 Hard palate	0.002	0.998	0.000
C08.9 Major salivary gland, unspecified	0.002	0.998	0.000
C08.8 Overlapping lesion of major salivary glands	0.002	0.998	0.000
C08.1 Sublingual gland	0.002	0.998	0.000
C08.0 Submandibular gland	0.002	0.998	0.000
C13.9 Hypopharynx, unspecified	0.002	0.998	0.000
C13.8 Overlapping lesion of hypopharynx	0.002	0.998	0.000
C13.2 Posterior wall of hypopharynx	0.002	0.998	0.000
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.002	0.998	0.000
C13.0 Postcricoid region	0.002	0.998	0.000
H40.3 Glaucoma secondary to eye trauma	0.002	0.998	0.000
H40.1 Primary open-angle glaucoma	0.002	0.998	0.000
A63.8 Other specified predominantly sexually transmitted diseases	0.002	0.998	0.000
C04.8 Overlapping lesion of floor of mouth	0.002	0.998	0.000
C04.1 Lateral floor of mouth	0.002	0.998	0.000
C04.0 Anterior floor of mouth	0.002	0.998	0.000
R40.2 Coma, unspecified	0.000	0.998	0.002
C04.9 Floor of mouth, unspecified	0.002	0.998	0.000
B24 Unspecified human immunodeficiency virus [HIV] disease	0.002	0.998	0.000
H43-H45 Disorders of vitreous body and globe	0.000	0.998	0.002
H43.2 Crystalline deposits in vitreous body	0.000	0.998	0.002
H43.0 Vitreous prolapse	0.000	0.998	0.002
M13.92 Arthritis, unspecified (Upper arm)	0.002	0.998	0.000
M13.98 Arthritis, unspecified (Other)	0.002	0.998	0.000
N20.2 Calculus of kidney with calculus of ureter	0.000	0.998	0.002
R41 Other symptoms and signs involving cognitive functions and awareness	0.000	0.998	0.002
A04.9 Bacterial intestinal infection, unspecified	0.002	0.998	0.000
H40.6 Glaucoma secondary to drugs	0.002	0.998	0.000
H44.0 Purulent endophthalmitis	0.000	0.998	0.002
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.000	0.998	0.002
M22.2 Patellofemoral disorders	0.000	0.998	0.002
M88 Paget's disease of bone [osteitis deformans]	0.002	0.998	0.000
H72.8 Other perforations of tympanic membrane	0.000	0.998	0.002
B20-B24 Human immunodeficiency virus [HIV] disease	0.002	0.998	0.000
A00-A09 Intestinal infectious diseases	0.002	0.998	0.000
M88.85 Paget's disease of other bones (Pelvic region and thigh)	0.002	0.998	0.000
M94.86 Other specified disorders of cartilage (Lower leg)	0.002	0.998	0.000
K82.9 Disease of gallbladder, unspecified	0.002	0.998	0.000
M88.8 Paget's disease of other bones	0.002	0.998	0.000
N20.1 Calculus of ureter	0.000	0.998	0.002
R45.8 Other symptoms and signs involving emotional state	0.000	0.998	0.002
A04.6 Enteritis due to Yersinia enterocolitica	0.002	0.998	0.000
A04.3 Enterohaemorrhagic Escherichia coli infection	0.002	0.998	0.000
A04.2 Enteroinvasive Escherichia coli infection	0.002	0.998	0.000
A04.1 Enterotoxigenic Escherichia coli infection	0.002	0.998	0.000
A04.0 Enteropathogenic Escherichia coli infection	0.002	0.998	0.000
C91 Lymphoid leukaemia	0.000	0.998	0.002
Chapter I Certain infectious and parasitic diseases	0.002	0.998	0.000
A09.0 Other and unspecified gastroenteritis and colitis of infectious origin	0.002	0.998	0.000
R52.1 Chronic intractable pain	0.002	0.998	0.000
F99 Mental disorder, not otherwise specified	0.000	0.998	0.002
R40 Somnolence, stupor and coma	0.000	0.998	0.002
H43.9 Disorder of vitreous body, unspecified	0.000	0.998	0.002
H72.0 Central perforation of tympanic membrane	0.000	0.998	0.002
K82.2 Perforation of gallbladder	0.002	0.998	0.000
B17.1 Acute hepatitis C	0.002	0.998	0.000
C15.8 Overlapping lesion of oesophagus	0.002	0.998	0.000
C15.2 Abdominal part of oesophagus	0.002	0.998	0.000
C15.1 Thoracic part of oesophagus	0.002	0.998	0.000
Z36.8 Other antenatal screening	0.000	0.998	0.002
A60 Anogenital herpesviral [herpes simplex] infections	0.001	0.998	0.000
A59 Trichomoniasis	0.001	0.998	0.000
A56 Other sexually transmitted chlamydial diseases	0.001	0.998	0.000
A54 Gonococcal infection	0.001	0.998	0.000
A53 Other and unspecified syphilis	0.001	0.998	0.000
A52 Late syphilis	0.001	0.998	0.000
A51 Early syphilis	0.001	0.998	0.000
A50 Congenital syphilis	0.001	0.998	0.000
A64 Unspecified sexually transmitted disease	0.001	0.998	0.000
A58 Granuloma inguinale	0.001	0.998	0.000
A57 Chancroid	0.001	0.998	0.000
A55 Chlamydial lymphogranuloma (venereum)	0.001	0.998	0.000
C91.0 Acute lymphoblastic leukaemia	0.000	0.998	0.002
G50.1 Atypical facial pain	0.002	0.998	0.000
I95.9 Hypotension, unspecified	0.000	0.998	0.002
K82.4 Cholesterolosis of gallbladder	0.002	0.998	0.000
B17 Other acute viral hepatitis	0.002	0.998	0.000
H72 Perforation of tympanic membrane	0.000	0.998	0.002
N20 Calculus of kidney and ureter	0.000	0.998	0.002
S05 Injury of eye and orbit	0.002	0.998	0.000
B17.8 Other specified acute viral hepatitis	0.002	0.998	0.000
C45.0 Mesothelioma of pleura	0.002	0.998	0.000
D72.8 Other specified disorders of white blood cells	0.002	0.998	0.000
S08 Traumatic amputation of part of head	0.002	0.998	0.000
S07 Crushing injury of head	0.002	0.998	0.000
S04 Injury of cranial nerves	0.002	0.998	0.000
S03 Dislocation, sprain and strain of joints and ligaments of head	0.002	0.998	0.000
B50-B64 Protozoal diseases	0.002	0.998	0.000
M89.98 Disorder of bone, unspecified (Other)	0.002	0.998	0.000
H40.5 Glaucoma secondary to other eye disorders	0.002	0.998	0.000
M89.92 Disorder of bone, unspecified (Upper arm)	0.002	0.998	0.000
B50.9 Plasmodium falciparum malaria, unspecified	0.001	0.998	0.000
B50 Plasmodium falciparum malaria	0.001	0.998	0.000
H45 Disorders of vitreous body and globe in diseases classified elsewhere	0.000	0.998	0.001
A15-A19 Tuberculosis	0.002	0.998	0.000
C15.3 Upper third of oesophagus	0.001	0.998	0.000
N21.0 Calculus in bladder	0.000	0.998	0.002
M94.89 Other specified disorders of cartilage (Site unspecified)	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations